Mai Capital Management Zoetis Inc. Transaction History

Mai Capital Management

$15.6 Billion
Q3 2025

A detailed history of Mai Capital Management transactions in Zoetis Inc. stock. As of the latest transaction made, Mai Capital Management holds 84,354 shares of ZTS stock, worth $10 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

84,354

Previous 100,784 16.3%

Holding current value

$10 Million

Previous $16.6 Million 25.62%

% of portfolio

0.08%

Previous 0.13%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$141.13 - $159.19 $2.32 Million - $2.62 Million	-16,430 Reduced 16.3%	84,354 $12.3 Million
Q1 2025 May 15, 2025	SELL	$156.48 - $175.67 $352,549 - $395,784	-2,253 Reduced 2.19%	100,784 $16.6 Million
Q4 2024 Feb 14, 2025	SELL	$162.24 - $194.42 $1.32 Million - $1.58 Million	-8,117 Reduced 7.3%	103,037 $16.8 Million
Q3 2024 Nov 07, 2024	SELL	$172.58 - $196.48 $840,637 - $957,054	-4,871 Reduced 4.2%	111,154 $21.7 Million
Q2 2024 Aug 12, 2024	SELL	$145.54 - $178.83 $78,154 - $96,031	-537 Reduced 0.46%	116,025 $20.1 Million

Q1 2024 May 08, 2024	BUY	$165.67 - $199.94 $3.47 Million - $4.19 Million	20,937 Added 21.89%	116,562 $19.7 Million
Q4 2023 Feb 09, 2024	BUY	$151.44 - $200.09 $2.31 Million - $3.05 Million	15,237 Added 18.95%	95,625 $18.9 Million
Q3 2023 Nov 14, 2023	BUY	$167.14 - $192.77 $4.26 Million - $4.91 Million	25,460 Added 46.35%	80,388 $14 Million
Q2 2023 Aug 02, 2023	BUY	$160.94 - $186.23 $7.98 Million - $9.24 Million	49,593 Added 929.58%	54,928 $9.46 Million
Q1 2023 May 10, 2023	BUY	$145.48 - $175.02 $49,608 - $59,681	341 Added 6.83%	5,335 $887,000
Q4 2022 Feb 09, 2023	BUY	$131.14 - $157.47 $219,659 - $263,762	1,675 Added 50.47%	4,994 $732,000
Q3 2022 Nov 15, 2022	BUY	$148.29 - $182.55 $16,311 - $20,080	110 Added 3.43%	3,319 $492,000
Q2 2022 Jul 19, 2022	SELL	$155.97 - $200.09 $307,416 - $394,377	-1,971 Reduced 38.05%	3,209 $552,000
Q1 2022 May 10, 2022	SELL	$181.39 - $234.03 $328,315 - $423,594	-1,810 Reduced 25.89%	5,180 $977,000
Q4 2021 Feb 11, 2022	BUY	$193.69 - $247.03 $432,316 - $551,370	2,232 Added 46.91%	6,990 $1.71 Million
Q3 2021 Nov 12, 2021	BUY	$189.29 - $209.69 $18,171 - $20,130	96 Added 2.06%	4,758 $924,000
Q2 2021 Jul 19, 2021	BUY	$155.9 - $187.99 $23,073 - $27,822	148 Added 3.28%	4,662 $869,000
Q1 2021 May 10, 2021	BUY	$144.0 - $169.39 $58,320 - $68,602	405 Added 9.86%	4,514 $711,000
Q4 2020 Feb 16, 2021	BUY	$157.07 - $174.35 $57,958 - $64,335	369 Added 9.87%	4,109 $680,000
Q3 2020 Oct 26, 2020	SELL	$137.1 - $165.37 $96,107 - $115,924	-701 Reduced 15.78%	3,740 $618,000
Q2 2020 Jul 27, 2020	BUY	$111.92 - $142.53 $6,827 - $8,694	61 Added 1.39%	4,441 $609,000
Q1 2020 Apr 16, 2020	SELL	$92.66 - $144.94 $57,819 - $90,442	-624 Reduced 12.47%	4,380 $515,000
Q4 2019 Feb 03, 2020	BUY	$116.25 - $133.25 $1,395 - $1,599	12 Added 0.24%	5,004 $662,000
Q3 2019 Oct 29, 2019	SELL	$112.57 - $128.43 $13,846 - $15,796	-123 Reduced 2.4%	4,992 $622,000
Q2 2019 Aug 15, 2019	SELL	$97.98 - $114.28 $10,483 - $12,227	-107 Reduced 2.05%	5,115 $581,000
Q1 2019 Apr 29, 2019	SELL	$81.56 - $100.67 $11,173 - $13,791	-137 Reduced 2.56%	5,222 $526,000
Q4 2018 Jan 30, 2019	BUY	$79.28 - $95.27 $217,623 - $261,516	2,745 Added 105.01%	5,359 $458,000
Q3 2018 Oct 12, 2018	SELL	$83.5 - $93.23 $3,507 - $3,915	-42 Reduced 1.58%	2,614 $239,000
Q2 2018 Aug 16, 2018	SELL	$79.9 - $89.2 $9,987 - $11,150	-125 Reduced 4.49%	2,656 $226,000
Q1 2018 Apr 17, 2018	SELL	$71.51 - $84.69 $51,058 - $60,468	-714 Reduced 20.43%	2,781 $232,000
Q4 2017 Jan 30, 2018	BUY	$63.24 - $72.8 $18,529 - $21,330	293 Added 9.15%	3,495 $252,000
Q3 2017 Oct 12, 2017	BUY	$59.73 - $65.4 $191,255 - $209,410	3,202	3,202 $204,000

Others Institutions Holding ZTS

# of Institutions

2,088

Shares Held

423M

Call Options Held

1.82M

Put Options Held

1.94M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $55.6B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Mai Capital Management with notifications on news.

Account

Mai Capital Management Zoetis Inc. Transaction History